In this study, we discovered both membrane and nonmembrane protein targets of MARCH8, i.e., CD44 and signal transducer and transcription activator 3 (STAT3), respectively, in different subtypes of breast cancer cells. Here, MARCHF8 is linked to breast carcinoma.